Research Shows Slow Development of Drugs for Neglected Diseases
November 6, 2013| |
Of the 850 new drugs and vaccines approved over the past decade, only 37 were for neglected diseases such as malaria, tuberculosis, chagas, sleeping sickness, and other diseases of poverty, according to a study published in The Lancet Global Health. Dr. Belen Pedrique and other authors called this as a "fatal imbalance" in the research and development of treatments for the world's poorest patients. Furthermore, there is only a few on going clinical trials on drugs for neglected diseases. They said that this can be attributed to the little financial incentive in investing in R&D of finding treatments for neglected diseases.
Read the original article at http://www.voanews.com/content/drug-development-lags-for-neglected-diseases/1776184.html and the research article at http://www.thelancet.com/journals/langlo/article/PIIS2214-109X(13)70078-0/fulltext.
| |
Biotech Updates is a weekly newsletter of ISAAA, a not-for-profit organization. It is distributed for free to over 22,000 subscribers worldwide to inform them about the key developments in biosciences, especially in biotechnology. Your support will help us in our mission to feed the world with knowledge. You can help by donating as little as $10.
-
See more articles:
-
News from Around the World
- Overcoming Smallholder Challenges with Biotechnology
- Raven: Biosafety Assessments Shouldn't be Burdensome
- Grant for Soybean Research Aims to Increase Africa's Food Supply
- Nigerian Agriculture Minister Urges Faster Acceptance of Biotech in Africa
- Biotechnology Center Re-established in Liberia
- Biologists Uncover Rules that Govern Leaf Design
- International Effort to Develop Climate-Resilient Wheat
- Research Improves Understanding of How Plants Protect Themselves from Adverse Environmental Conditions
- Genes in the Organelles Affects Cell Metabolism
- Australian OGTR DIR 122 - Notification of Decision on GM Wheat Field Trial
- Top Rice Research Showcased in International Symposium
- Philippine DA Allows Field Trials of GM Crops
- Regulators and Experts from 8 Asian Countries Train on Communicating Biotech and Biosafety
- EU Prepares Draft of New GM Maize Cultivation Approval
- Study Shows New Technologies Not Perfect but Very Beneficial
-
Research Highlights
- Pyramiding of the HVA1 and mtlD in Maize Confers Drought and Salt Tolerance
- GE Sweet Potato with Multiple Virus Resistance Developed
-
Beyond Crop Biotech
- Research Shows Slow Development of Drugs for Neglected Diseases
- "Flipping" Genetic Switch Reveals New Compounds with Antibiotic Potential
-
Announcements
- Global Forum for Innovations in Agriculture
-
Resources
- Transgenic Technologies in Agriculture: From Lab to Field to Market
-
Read the latest: - Biotech Updates (April 17, 2024)
- Gene Editing Supplement (April 10, 2024)
- Gene Drive Supplement (February 22, 2023)
-
Subscribe to BU: - Share
- Tweet